News & Updates
Filter by Specialty:
MRNA shots effective against COVID-19 Delta variant
Immunizations with mRNA-based vaccines are strongly effective against symptomatic and severe COVID-19 disease associated with the virus’ Delta variant, according to a recent Singapore study.
MRNA shots effective against COVID-19 Delta variant
11 Aug 2022Teclistamab demonstrates clinical activity for R/R MM
The T-cell-redirecting bispecific antibody teclistamab induced deep and durable responses in patients with triple-class-exposed relapsed or refractory multiple myeloma (R/R MM), findings from the phase I/II MajesTEC-1 trial have shown.
Teclistamab demonstrates clinical activity for R/R MM
11 Aug 2022Coagulation abnormalities compromise COVID-19 survival
Patients with abnormalities in coagulation parameters such as prothrombin concentration (PC) and D-dimer (DD) levels are at greater risk of more severe COVID-19 infection and subsequent death, reports a recent study.
Coagulation abnormalities compromise COVID-19 survival
11 Aug 2022Canagliflozin blunts end-stage renal disease risk in T2DM patients with CKD
In patients with type 2 diabetes mellitus (T2DM) with chronic kidney disease (CKD), treatment with canagliflozin safely decreases the risk of developing end-stage renal disease, reports a new Japan study.
Canagliflozin blunts end-stage renal disease risk in T2DM patients with CKD
11 Aug 20221 week off methotrexate works okay for RA patients receiving flu shot
Temporarily discontinuing methotrexate treatment for 1 week appears to induce satisfactory response to a seasonal influenza vaccine in patients with rheumatoid arthritis (RA), with a similar effect as a 2-week interruption schedule, according to a study.